What Tesamorelin is
Tesamorelin is a synthetic analogue of human GHRH(1-44) with an N-terminal modification that improves stability relative to native GHRH. That stability is the reason it appears in endocrine signalling studies where native GHRH degrades too quickly.
It is listed as a laboratory reference material for in-vitro research only and is not offered for human or veterinary use. A research-use label does not by itself determine regulatory status; see the compliance page for official TGA guidance.
What the published research investigates
Published work examines GHRH receptor pharmacology, pituitary signalling models and comparative studies against other secretagogue peptides such as Sermorelin and Ipamorelin.
Read the primary literature via the PubMed link below rather than relying on supplier summaries.
Storage & handling in the lab
Aussie Peptides does not publish product- or lot-specific preparation, storage or stability data. Base preparation, storage and disposal on the supplier safety data sheet (SDS) and your institution's standard operating procedures.
Where a vial label shows a lot number and a batch report has been published for that lot, it can be looked up on the verify page and recorded alongside your experimental data.
Legal status in Australia
Materials on this site are supplied strictly for in-vitro laboratory research. They are not offered for human or veterinary use. A research-use label does not by itself determine regulatory status; see the compliance page for official TGA guidance.
Purchasers must be 18 or over and are responsible for handling, storing and disposing of research materials in line with their institution's requirements and applicable Australian law.
Nothing on this page is medical advice, a dosing protocol, or a claim of therapeutic benefit. It summarises what the published research literature investigates.
Common questions
Both are GHRH-based peptides, but Tesamorelin carries an N-terminal modification that increases stability. Comparative pharmacology between the two is a common subject in the literature.
This material is listed for in-vitro laboratory research only and is not offered for human or veterinary use. A research-use label does not by itself determine regulatory status; see our compliance page for the official TGA guidance. Purchasers must be 18 or over.
Where a batch report has been published for a given lot, it can be looked up on the verify page.
Tesamorelin checklist & safety notes.
A one-page laboratory checklist for Tesamorelin: lot record-keeping, packaging inspection on arrival, and how to read a batch report where one is published. Handling and storage follow the supplier SDS and your institution's SOPs. Research use only — no human dosing protocols.
One email, no list sharing. 18+ research use only.